Pensionfund DSM Netherlands purchased a new stake in Cigna Corporation (NYSE:CI) in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 22,000 shares of the health services provider’s stock, valued at approximately $4,113,000.

Several other institutional investors also recently added to or reduced their stakes in the company. Eqis Capital Management Inc. boosted its holdings in shares of Cigna Corporation by 3.1% in the third quarter. Eqis Capital Management Inc. now owns 8,949 shares of the health services provider’s stock valued at $1,673,000 after buying an additional 267 shares during the period. Ardsley Advisory Partners acquired a new position in shares of Cigna Corporation in the second quarter valued at approximately $418,000. Achmea Investment Management B.V. boosted its holdings in shares of Cigna Corporation by 73.7% in the second quarter. Achmea Investment Management B.V. now owns 18,365 shares of the health services provider’s stock valued at $3,073,000 after buying an additional 7,791 shares during the period. Lord Abbett & CO. LLC boosted its holdings in shares of Cigna Corporation by 2.8% in the second quarter. Lord Abbett & CO. LLC now owns 43,600 shares of the health services provider’s stock valued at $7,298,000 after buying an additional 1,200 shares during the period. Finally, Toronto Dominion Bank boosted its holdings in shares of Cigna Corporation by 25.0% in the second quarter. Toronto Dominion Bank now owns 86,740 shares of the health services provider’s stock valued at $14,517,000 after buying an additional 17,348 shares during the period. Institutional investors own 87.95% of the company’s stock.

In other Cigna Corporation news, Director William D. Zollars sold 1,232 shares of Cigna Corporation stock in a transaction on Wednesday, September 13th. The shares were sold at an average price of $187.23, for a total transaction of $230,667.36. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, VP Mary T. Hoeltzel sold 525 shares of Cigna Corporation stock in a transaction on Wednesday, August 9th. The stock was sold at an average price of $177.59, for a total transaction of $93,234.75. Following the transaction, the vice president now directly owns 1,924 shares in the company, valued at $341,683.16. The disclosure for this sale can be found here. Insiders have sold a total of 70,653 shares of company stock worth $12,437,684 over the last ninety days. Insiders own 1.30% of the company’s stock.

WARNING: This piece was posted by Daily Political and is the property of of Daily Political. If you are viewing this piece on another site, it was copied illegally and republished in violation of U.S. & international copyright law. The correct version of this piece can be viewed at https://www.dailypolitical.com/2017/10/18/pensionfund-dsm-netherlands-purchases-shares-of-22000-cigna-corporation-ci.html.

Cigna Corporation (NYSE:CI) traded up 1.40% during mid-day trading on Wednesday, reaching $189.83. 1,435,833 shares of the company’s stock traded hands. The stock has a market cap of $47.80 billion, a P/E ratio of 21.90 and a beta of 0.43. The company has a 50 day moving average price of $185.32 and a 200-day moving average price of $170.46. Cigna Corporation has a 12 month low of $115.03 and a 12 month high of $193.00.

Cigna Corporation (NYSE:CI) last posted its quarterly earnings data on Friday, August 4th. The health services provider reported $2.91 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.48 by $0.43. The firm had revenue of $10.32 billion for the quarter, compared to the consensus estimate of $10.26 billion. Cigna Corporation had a net margin of 5.55% and a return on equity of 17.40%. The business’s revenue for the quarter was up 3.6% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.98 EPS. On average, analysts anticipate that Cigna Corporation will post $10.03 EPS for the current year.

Several research firms have recently weighed in on CI. UBS AG reiterated a “buy” rating and issued a $193.00 price target (up previously from $186.00) on shares of Cigna Corporation in a report on Thursday, June 22nd. Deutsche Bank AG increased their target price on shares of Cigna Corporation from $175.00 to $180.00 and gave the stock a “buy” rating in a report on Thursday, July 13th. Royal Bank Of Canada restated a “buy” rating and set a $182.00 target price on shares of Cigna Corporation in a report on Monday, July 24th. Bank of America Corporation increased their target price on shares of Cigna Corporation from $193.00 to $198.00 and gave the stock a “buy” rating in a report on Friday, June 23rd. Finally, BidaskClub upgraded shares of Cigna Corporation from a “buy” rating to a “strong-buy” rating in a report on Friday, August 18th. Two investment analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has assigned a strong buy rating to the company. Cigna Corporation currently has an average rating of “Buy” and a consensus target price of $193.44.

Cigna Corporation Company Profile

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Institutional Ownership by Quarter for Cigna Corporation (NYSE:CI)

Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with MarketBeat.com's FREE daily email newsletter.